Evaluation of subjective treatment satisfaction with antipsychotics in schizophrenia patients

An evaluation of overall effectiveness and treatment satisfaction with intravenous immunoglobulin among patients with immune thrombocytopenia

“…In the cohort that used corticosteroids (n 5 542), 55% were highly bothered by side effects and 38% needed to stop or reduce treatment. 36 The side effect scores we obtained in this pilot study were most comparable to patients receiving multiple oral medications to treat diabetes, 20,21 multiple antipsychotic medications for schizophrenia, 19 and combination oral antihypertensive medications. 27 Studies measuring treatment satisfaction using the TSQM have demonstrated that increased satisfaction with treatment has implications for the improvement of other patient important outcomes.…”

“…Previously, investigators have used the TSQM to evaluate a number of medications including subcutaneously injected and topical treatments for patients with psoriasis; [16][17][18] oral medications for patients with schizophrenia, 19 type II diabetes, 20-22 glomerulosclerosis, 23 osteoarthritis, 24 postmenopausal osteoporosis, 25 epilepsy, 26 and hypertension; 27 and inhaled medications for patients with cystic fibrosis 28 and pulmonary arterial hypertension, 29 among others. [30][31][32] Additionally, only two studies have been conducted assessing the treatment satisfaction in an IV administered medication (epoprostenol, indicated for patients with pulmonary arterial hypertension).…”

Satisfaction and Side Effects in Outpatients with Schizophrenia Medicated with Antipsychotics

“…A limitation of the present study was that the number of NS-SGA subjects was too small (n=5); therefore, the influence of side effects on satisfaction could not be detected. Another Japanese study using TSQM showed that satisfaction with regard to side effects was higher with SGA, although they did not differentiate the SGA into S-SGA and NS-SGA 16) . The influence of side effects on satisfaction may be clarified in future studies using a larger number of subjects in the S-SGA and NS-SGA groups.…”

Treatment response and tolerability with once-monthly paliperidone palmitate initiated shortly after hospital admission in patients with schizophrenia

“…Treatment satisfaction has been recognised as an important aspect of determining treatment effectiveness (Juckel et al 2014), and is also an important factor for treatment adherence (Atkinson et al 2004;Fujikawa et al 2008).…”